This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Polypharmacy in CKD: a reason to review, not withhold, cardiorenal protection

  • Canagliflozin and polypharmacy burden in CKD

  • ASN Kidney health guidance on the cardiovascular-kidney-metabolic syndrome

  • Laboratory sample analyser

    Proteomic insights into dapagliflozin in CKD

  • Gleaming stethoscope on laptop

    A FINE time to be a nephrologist

  • Pharmacist selecting medicine.

    Finerenone and chronic kidney disease without diabetes

  • GP consultation

    An integrated primary care model for cardiorenal-metabolic disease

  • Healthcare professional talking to patient

    Missed opportunities to detect and treat CKD in patients with coronary artery disease

  • Laboratory worker analysing samples

    INTERASPIRE: CKD screening in people with coronary artery disease

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe